Taiyo Holdings Co., Ltd. Revises Earnings Forecast Upward on Electronics Strength
Taiyo Holdings Co., Ltd. (TSE:4626) has raised its earnings guidance for the fiscal year ending March 2027, citing stronger-than-expected performance in its electronics business and favorable currency movements.
| Item | Before | After | Change | Change % |
|---|---|---|---|---|
| H1 Cumulative | ||||
| Revenue | JPY 73.1bn | JPY 75.9bn | JPY 2.8bn | 3.8% |
| Operating Profit | JPY 16.8bn | JPY 18.9bn | JPY 2.1bn | 12.5% |
| Ordinary Income | JPY 16.3bn | JPY 19.2bn | JPY 2.9bn | 17.8% |
| Net Profit | JPY 11.8bn | JPY 13.1bn | JPY 1.3bn | 11.0% |
| EPS | JPY 106.11/share | JPY 117.73/share | JPY 11.62/share | 10.9% |
| Full Year | ||||
| Revenue | JPY 146.3bn | JPY 149.1bn | JPY 2.8bn | 1.9% |
| Operating Profit | JPY 34.3bn | JPY 36.4bn | JPY 2.1bn | 6.1% |
| Ordinary Income | JPY 33.4bn | JPY 36.3bn | JPY 2.9bn | 8.7% |
| Net Profit | JPY 24.1bn | JPY 25.4bn | JPY 1.3bn | 5.4% |
| EPS | JPY 216.72/share | JPY 228.26/share | JPY 11.54/share | 5.3% |
The company attributed the upward revision to first-quarter outperformance in its electronics division, where rigid substrate materials for China-bound products exceeded demand expectations. A weaker yen than initially forecast also provided tailwinds. The company recorded employee special benefit expenses as an extraordinary loss in Q1. Guidance for the medical-pharmaceutical and ICT&S segments remains unchanged.
The revision signals momentum in Taiyo Holdings’ core electronics business despite macroeconomic headwinds. Operating profit and ordinary income (keijo rieki)—a Japan-specific metric combining operating profit with non-operating income and expenses—are both tracking double-digit growth rates. The company maintained its dividend forecast unchanged, suggesting incremental profit gains will be retained for reinvestment or balance-sheet strengthening rather than distributed to shareholders.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Always verify against the original filing.